Compare $MLYS vs $VIR | Chartloom

Compare

$MLYS vs $VIR

Mineralys Therapeutics Inc · Vir Biotechnology Inc

MLYS

Mineralys Therapeutics Inc

VIR

Vir Biotechnology Inc

Compare $MLYS vs $VIR

Comparing Mineralys Therapeutics Inc and Vir Biotechnology Inc

MLYSMineralys Therapeutics Inc

VIRVir Biotechnology Inc

MLYSMineralys Therapeutics Inc

Market cap

$2.06B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

30.20x

Rev growth (TTM)

—

YTD performance

-34.6%

52W performance

-37.7%

FCF yield

-16.5%

VIRVir Biotechnology Inc

Market cap

$1.97B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

36.09x

Rev growth (TTM)

1496.1%

YTD performance

97.0%

52W performance

93.4%

FCF yield

-10.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MLYS

VIR

Detailed metrics comparison

MLYS

Mineralys Therapeutics Inc

VIR

Vir Biotechnology Inc

Market Cap

MLYS$2.06B

VIR$1.97B

Enterprise Value

MLYS$2.02B

VIR$1.69B

Price

MLYS$23.37

VIR$11.70

P/E Ratio

MLYSN/A

VIRN/A

P/S Ratio

MLYS0.00x

VIR6.51x

EV/Sales

MLYS0.00x

VIR5.59x

EV/EBITDA

MLYS0.00x

VIR1.92x

P/B Ratio

MLYS3.79x

VIR1.92x

P/FCF Ratio

MLYSN/A

VIRN/A

EV/FCF

MLYS-5.96x

VIR-8.32x

PEG Ratio

MLYSN/A

VIRN/A

Forward P/E (NTM)

MLYSN/A

VIRN/A

Forward P/S (NTM)

MLYS30.20x

VIR36.09x

Revenue (TTM)

MLYS$0

VIR$303M

Revenue Growth (YoY)

MLYSN/A

VIR1496.1%

Forward Rev Growth

MLYS106.7%

VIR-58.9%

Gross Margin (TTM)

MLYS0.0%

VIR100.0%

Operating Margin (TTM)

MLYS0.0%

VIR0.0%

EBITDA Margin (TTM)

MLYS0.0%

VIR-45.9%

Net Margin (TTM)

MLYS0.0%

VIR-41.5%

FCF Margin (TTM)

MLYSN/A

VIR-67.1%

Net Income (TTM)

MLYS$-350M

VIR$-126M

FCF (TTM)

MLYS$-339M

VIR$-204M

EPS (TTM)

MLYS-$4.13

VIR-$0.75

ROE (TTM)

MLYS-5797.0%

VIR-1486.0%

ROA (TTM)

MLYS-5415.0%

VIR-1168.0%

ROIC (TTM)

MLYS-5571.0%

VIR-1486.0%

Cash

MLYS$138M

VIR$279M

Debt

MLYS$98M

VIR$0

Net Cash/Debt

MLYS$41M

VIR$279M

Current Ratio (TTM)

MLYS34.46x

VIR6.04x

Quick Ratio (TTM)

MLYS34.24x

VIR5.69x

Debt/Equity (TTM)

MLYS0.18x

VIR0.00x

Debt/Assets (TTM)

MLYS0.0%

VIR0.0%

Interest Coverage (TTM)

MLYSN/A

VIRN/A

Net Debt/EBITDA (TTM)

MLYS0.00x

VIR0.00x

Beta

MLYS0.64

VIR1.77

52W Performance

MLYS-37.7%

VIR93.4%

YTD Performance

MLYS-34.6%

VIR97.0%

% from 52W High

MLYS-51.0%

VIR-2.6%

% from 52W Low

MLYS8.9%

VIR143.0%

Asset Turnover (TTM)

MLYS0.00x

VIR0.28x

FCF Yield (TTM)

MLYS-16.5%

VIR-10.3%

Earnings Yield (TTM)

MLYS-17.0%

VIR-6.4%

Dividend Yield (TTM)

MLYSN/A

VIRN/A

Rule of 40

MLYS0.0

VIR1,428.9

EV/GP/RG

MLYSN/A

VIRN/A

Ticker research

View MLYS research View VIR research

Metric	MLYS Mineralys Therapeutics Inc	VIR Vir Biotechnology Inc
Market & Valuation
Market Cap	$2.06B	$1.97B
Enterprise Value	$2.02B	$1.69B
Price	$23.37	$11.70
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	6.51x
EV/Sales	0.00x	5.59x
EV/EBITDA	0.00x	1.92x
P/B Ratio	3.79x	1.92x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.96x	-8.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	30.20x	36.09x
Revenue & Growth
Revenue (TTM)	$0	$303M
Revenue Growth (YoY)	N/A	1496.1%
Forward Rev Growth	106.7%	-58.9%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-45.9%
Net Margin (TTM)	0.0%	-41.5%
FCF Margin (TTM)	N/A	-67.1%
Net Income (TTM)	$-350M	$-126M
FCF (TTM)	$-339M	$-204M
EPS (TTM)	-$4.13	-$0.75
ROE (TTM)	-5797.0%	-1486.0%
ROA (TTM)	-5415.0%	-1168.0%
ROIC (TTM)	-5571.0%	-1486.0%
Financial Health
Cash	$138M	$279M
Debt	$98M	$0
Net Cash/Debt	$41M	$279M
Current Ratio (TTM)	34.46x	6.04x
Quick Ratio (TTM)	34.24x	5.69x
Debt/Equity (TTM)	0.18x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.64	1.77
52W Performance	-37.7%	93.4%
YTD Performance	-34.6%	97.0%
% from 52W High	-51.0%	-2.6%
% from 52W Low	8.9%	143.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.28x
FCF Yield (TTM)	-16.5%	-10.3%
Earnings Yield (TTM)	-17.0%	-6.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	1,428.9
EV/GP/RG	N/A	N/A
Ticker research	View MLYS research	View VIR research

Valuation

P/S Ratio

MLYS

0.00x

VIR

6.51x

EV/FCF

VIR

-8.32x

MLYS

-5.96x

Growth & revenue

Revenue Growth TTM

VIR

1496.1%

Forward Revenue Growth

MLYS

106.7%

VIR

-58.9%

Profitability & performance

Gross Margin

VIR

100.0%

MLYS

0.0%

ROE

VIR

-1486.0%

MLYS

-5797.0%

FCF Yield %

VIR

-10.3%

MLYS

-16.5%

52-Week Performance

VIR

93.4%

MLYS

-37.7%

Detailed metrics comparison

MLYS

Mineralys Therapeutics Inc

VIR

Vir Biotechnology Inc

Market Cap

MLYS$2.06B

VIR$1.97B

Enterprise Value

MLYS$2.02B

VIR$1.69B

Price

MLYS$23.37

VIR$11.70

P/E Ratio

MLYSN/A

VIRN/A

P/S Ratio

MLYS0.00x

VIR6.51x

EV/Sales

MLYS0.00x

VIR5.59x

EV/EBITDA

MLYS0.00x

VIR1.92x

P/B Ratio

MLYS3.79x

VIR1.92x

P/FCF Ratio

MLYSN/A

VIRN/A

EV/FCF

MLYS-5.96x

VIR-8.32x

PEG Ratio

MLYSN/A

VIRN/A

Forward P/E (NTM)

MLYSN/A

VIRN/A

Forward P/S (NTM)

MLYS30.20x

VIR36.09x

Revenue (TTM)

MLYS$0

VIR$303M

Revenue Growth (YoY)

MLYSN/A

VIR1496.1%

Forward Rev Growth

MLYS106.7%

VIR-58.9%

Gross Margin (TTM)

MLYS0.0%

VIR100.0%

Operating Margin (TTM)

MLYS0.0%

VIR0.0%

EBITDA Margin (TTM)

MLYS0.0%

VIR-45.9%

Net Margin (TTM)

MLYS0.0%

VIR-41.5%

FCF Margin (TTM)

MLYSN/A

VIR-67.1%

Net Income (TTM)

MLYS$-350M

VIR$-126M

FCF (TTM)

MLYS$-339M

VIR$-204M

EPS (TTM)

MLYS-$4.13

VIR-$0.75

ROE (TTM)

MLYS-5797.0%

VIR-1486.0%

ROA (TTM)

MLYS-5415.0%

VIR-1168.0%

ROIC (TTM)

MLYS-5571.0%

VIR-1486.0%

Cash

MLYS$138M

VIR$279M

Debt

MLYS$98M

VIR$0

Net Cash/Debt

MLYS$41M

VIR$279M

Current Ratio (TTM)

MLYS34.46x

VIR6.04x

Quick Ratio (TTM)

MLYS34.24x

VIR5.69x

Debt/Equity (TTM)

MLYS0.18x

VIR0.00x

Debt/Assets (TTM)

MLYS0.0%

VIR0.0%

Interest Coverage (TTM)

MLYSN/A

VIRN/A

Net Debt/EBITDA (TTM)

MLYS0.00x

VIR0.00x

Beta

MLYS0.64

VIR1.77

52W Performance

MLYS-37.7%

VIR93.4%

YTD Performance

MLYS-34.6%

VIR97.0%

% from 52W High

MLYS-51.0%

VIR-2.6%

% from 52W Low

MLYS8.9%

VIR143.0%

Asset Turnover (TTM)

MLYS0.00x

VIR0.28x

FCF Yield (TTM)

MLYS-16.5%

VIR-10.3%

Earnings Yield (TTM)

MLYS-17.0%

VIR-6.4%

Dividend Yield (TTM)

MLYSN/A

VIRN/A

Rule of 40

MLYS0.0

VIR1,428.9

EV/GP/RG

MLYSN/A

VIRN/A

Ticker research

View MLYS research View VIR research

Metric	MLYS Mineralys Therapeutics Inc	VIR Vir Biotechnology Inc
Market & Valuation
Market Cap	$2.06B	$1.97B
Enterprise Value	$2.02B	$1.69B
Price	$23.37	$11.70
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	6.51x
EV/Sales	0.00x	5.59x
EV/EBITDA	0.00x	1.92x
P/B Ratio	3.79x	1.92x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.96x	-8.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	30.20x	36.09x
Revenue & Growth
Revenue (TTM)	$0	$303M
Revenue Growth (YoY)	N/A	1496.1%
Forward Rev Growth	106.7%	-58.9%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-45.9%
Net Margin (TTM)	0.0%	-41.5%
FCF Margin (TTM)	N/A	-67.1%
Net Income (TTM)	$-350M	$-126M
FCF (TTM)	$-339M	$-204M
EPS (TTM)	-$4.13	-$0.75
ROE (TTM)	-5797.0%	-1486.0%
ROA (TTM)	-5415.0%	-1168.0%
ROIC (TTM)	-5571.0%	-1486.0%
Financial Health
Cash	$138M	$279M
Debt	$98M	$0
Net Cash/Debt	$41M	$279M
Current Ratio (TTM)	34.46x	6.04x
Quick Ratio (TTM)	34.24x	5.69x
Debt/Equity (TTM)	0.18x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.64	1.77
52W Performance	-37.7%	93.4%
YTD Performance	-34.6%	97.0%
% from 52W High	-51.0%	-2.6%
% from 52W Low	8.9%	143.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.28x
FCF Yield (TTM)	-16.5%	-10.3%
Earnings Yield (TTM)	-17.0%	-6.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	1,428.9
EV/GP/RG	N/A	N/A
Ticker research	View MLYS research	View VIR research